Hyaluronic Injection 1.5% (Sodium Hyaluronate)
Sodium Hyaluronate 15mg
Injections · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
MFDS item code 201100041 · Notified 2011.01.06 · Insurance code 643505841
Adjunctive treatment for ophthalmic surgery (cataract surgery, corneal transplantation, etc.)
This medication is used to assist in various ophthalmic surgeries such as lens implantation during cataract surgery, corneal transplant surgery, and glaucoma surgery. It plays an important role in aiding recovery after ophthalmic surgery and enhancing surgical efficacy. Patients may benefit from this medication in preventing postoperative complications and speeding recovery. It is effectively used for individuals undergoing ophthalmic surgery.
1. Cataract surgery and intraocular lens implantation: Slowly inject the required amount of this medicine into the anterior chamber of the eye through a needle or cannula before or after lens removal. Since the optimal corneal endothelial protective effect as an adjuvant may be achieved only when injected before cataract extraction and intraocular lens insertion, inject before intracapsular and extracapsular cataract surgery. This medicine may be used to coat surgical instruments and the intraocular lens to be implanted. 2. Corneal transplantation: After removing the corneal graft, fill the anterior chamber with this medicine until it is level with the corneal surface. Place the donor graft on this medicine and suture it. 3. Glaucoma filtration surgery: Inject this medicine through a corneal paracentesis to replenish and maintain the anterior chamber volume during trabeculectomy.
This medication is an ophthalmic injection made with sodium hyaluronate. First, this medication should not be used in patients who have had allergic reactions to its components or to medications of protein origin. Various side effects may occur in the eyes while using this medication. For example, intraocular pressure may temporarily increase, inflammation may occur, and corneal edema or opacity may develop. Additionally, abnormalities in the iris, pain, itching, and vision loss may appear. Furthermore, opacity may develop on the surface of the intraocular lens, and since this medication contains phosphate, calcification of the cornea may rarely occur in patients with severe corneal damage. After surgery, special care should be taken to monitor intraocular pressure closely, and appropriate treatment should be administered if the pressure rises. If possible, it is preferable to wash or aspirate this medication after surgery. Before ultrasound emulsification surgery, aspiration and perfusion should create a space filled with perfusion fluid between the lens and this medication. Moreover, it is advisable to avoid cleaning surgical instruments with solutions containing benzalkonium chloride or other quaternary ammonium compounds. This medication should not be used in conjunction with a drug called hyaluronidase. The administration method must follow the prescribed dosages and usages for ophthalmic use, and it should never be injected intravenously. Before use, this medication should be kept at refrigerated temperatures and brought to room temperature for about 30 minutes, and it should only be used once after opening, with any unused portion being discarded. When mixing this medication with air, care should be taken to prevent air from entering beneath the iris, and slow and careful injection is required. When administering to the anterior chamber, care should be taken to avoid overdose, as overdose may lead to increased intraocular pressure post-surgery. During storage, keep it out of reach of children, avoid direct sunlight, and store it sealed in a cool, dry place.
Increased intraocular pressure, inflammatory response, corneal edema, corneal opacity, anterior hemorrhage, iris neovascularization, posterior iris ulcer, conjunctival adhesions, mydriasis, lenticular opacification, ocular pain, pruritus, blurred vision, corneal functional impairment, opacification of the intraocular lens surface, corneal calcification
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a sealed container blocking light. Additionally, it is important to store it in a refrigerated temperature between 2 to 8 degrees Celsius to maintain its efficacy.
A colorless, transparent, and viscous liquid contained in a colorless and transparent pre-filled syringe sealed with rubber stoppers at both ends.
1 pre-filled syringe/box [pre-filled syringe (0.85mL)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sodium Hyaluronate 15mg
Injections · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Sodium Hyaluronate 10mg
Prescription medication
Dongkuk Pharmaceutical Co., Ltd.
Sodium Hyaluronate 10mg
Prescription medication
Youyoung Pharmaceutical Co., Ltd.
Sodium Hyaluronate 1mg
Eye drops · Prescription medication
Samil Pharmaceutical Co., Ltd.
Sodium Hyaluronate 10mg
Injections · Prescription medication
Alcon Korea Co., Ltd.
Sodium Hyaluronate 10mg
Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sodium Hyaluronate 10mg
Prescription medication
Donggwang Pharmaceutical Co., Ltd.
Sodium Hyaluronate 10mg
Prescription medication
Iyeon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.